Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Saori Fukuda has a total of 210 co-authors. Here are the top co-authors by number of shared publications:

  • Satoshi Komoto

    Division of One Health, Research Center for GLOBAL and LOCAL Infectious Diseases (RCGLID), Oita University, Yufu 879-5593, Oita, Japan

    26 shared publications
  • Koki Taniguchi

    Department of Virology Fujita Health University School of Medicine Toyoake Japan

    24 shared publications
  • Takayuki Murata

    Department of Virology, Fujita Health University School of Medicine, Toyoake 470-1192, Aichi, Japan

    15 shared publications
  • Riona Hatazawa

    Department of Virology, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan

    12 shared publications
  • Tomihiko Ide

    Department of Virology and Parasitology, Fujita Health University School of Medicine, Japan

    11 shared publications
  • Ratana Tacharoenmuang

    Enteric Viruses Section, National Institute of Health, Department of Medical Sciences, Nonthaburi, 11000, Thailand

    8 shared publications

Latest Publications

  • Open Access

    A human sensory neuron model for varicella-zoster virus latency and reactivation in vitro

    by Alexander C. Havelaar, Joseph S. Flot, Saori Fukuda, Anja W. M. de Jong, R. I. Koning, Amber Schotting, Sem van 'T Geloof, Tomohiko Sadaoka, Georges M. G. M. Verjans, Paul R. Kinchington, et al.

    Varicella-zoster virus (VZV) is a ubiquitous human neurotropic alphaherpesvirus that establishes lifelong latency in sensory ganglionic neurons. Subsequent viral reactivation causes herpes zoster, a morbid disease often complicated by neuropathic pain. Mechanisms underlying VZV latency and reactivation are not understood, mostly due to the lack of permissive animal models and challenges of current in vitro latency modeling. Here, we evaluated HD10.6 cells, a simplified and easily expandable human sensory neuron line to model VZV latency and reactivation. Differentiated HD10.6 (dHD10.6) neurons supported productive VZV infection, viral DNA replication, production of infectious progeny, and viral spread in cultures. VZV infection was associated with limited cytopathic effects and ultrastructural changes. Infecting dHD10.6 neurons with cell-free VZV in the presence of antivirals resulted in a quiescent-persistent state, characterized by persistent VZV genomes with restricted VZV gene expression and absence of infectious virus. Importantly, VZV could be reactivated by treatment with capsaicin, as evidenced by increased lytic viral transcription and virus spread. In conclusion, this study establishes human HD10.6 neurons as a novel and expandable in vitro model for studying VZV latency and reactivation to identify virus and host factors governing latency that may serve as therapeutic targets to restrict VZV reactivation. IMPORTANCE: Most individuals carry latent varicella-zoster virus (VZV) in their dorsal root ganglia (DRG), which can reactivate to cause shingles and chronic pain. The mechanisms by which VZV establishes latency and triggers of reactivation are incompletely understood. Current platforms for the study of VZV latency do not easily support functional experiments (ganglia) or are difficult to expand and complicated by mixed neuronal populations (stem cell-derived neurons). Here, we demonstrate that differentiated HD10.6 cells derived from immortalized human DRG-derived neurons provide a clonal and easy-to-expand platform for studying lytic, latent, and reactivated VZV infection in sensory neurons. We propose that the HD10.6 platform could provide the basis to conduct studies on the viral latent state that have hitherto not been possible.

  • Open Access

    The First Whole-Genome Characterization of a Kenyan DS-1-like G3P[8] Rotavirus Strain: Evidence for an Intragenogroup Reassortment Event in Africa

    by Yuki Akari, Aoko J. Ogutha, Maurine M. Mutua, Mary Wachira, Carlene Sang, Saori Fukuda, Ryoko Shiraishi, James Nyangao, Samoel A. Khamadi, Shingo Inoue, et al.

    Unusual DS-1-like G3P[8] rotavirus strains have emerged and spread rapidly across several countries. In Africa, however, reports of these strains and available whole-genome data remain limited, and their evolutionary relationships across the continent are not yet fully understood. In this study, we sequenced and characterized the complete genome of a DS-1-like G3P[8] strain (RVA/Human-wt/KEN/KCH1748/2020/G3P[8]) detected in a child with acute gastroenteritis in Kenya. Strain KCH1748 possessed an unusual genotype constellation: G3-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2. Phylogenetic analysis revealed that 10 of the 11 genomic segments of strain KCH1748 were closely related to those of other East African DS-1-like G3P[8] strains from Kenya and Tanzania within the globally circulating DS-1-like G3P[8] lineage, suggesting that it may be derived from this globally emerging lineage. In contrast, the VP1 gene of strain KCH1748 was closely related to those of Ghanaian G9P[4] strains, sharing a common branch with Beninese DS-1-like G3P[8] and G2P[4] strains, suggesting a VP1 intragenogroup reassortment event involving African RVA strains. This study provides the first comprehensive whole-genome evolutionary characterization of a DS-1-like G3P[8] strain identified in Kenya. Our findings contribute to understanding the evolutionary dynamics and genomic diversification of emerging DS-1-like G3P[8] strains in Africa.

  • Open Access

    Two Lineages of DS‐1‐Like G3P[8] Human Rotaviruses in Sabah, Malaysia: Genetic Diversity and Evidence of Reassortment

    by Yuki Akari, Lia Natasha Amit, Jecelyn Leaslie John, Daisuke Mori, Abraham Zefong Chin, Andau Konodan Mosiun, Saori Fukuda, Maurine Mumo Mutua, Ibuki Sato, Yoshimasa Maeno, et al.

    Group A rotavirus (RVA) genotype G3P[8] strains typically carry a Wa‐like genomic backbone, but DS‐1‐like G3P[8] reassortants have disseminated globally since 2013. In Sabah, Malaysia, surveillance in 2018–2019 identified frequent G3P[8] strains with a short RNA electropherotype, consistent with DS‐1‐like backbones. Here, we sequenced whole genomes (Illumina MiSeq) of seven representative short‐pattern strains (KN4, KN7, L39, L68, L116, L222, and L286) and a co‐circulating long‐pattern Wa‐like G3P[8] strain (L86). Six short‐pattern strains possessed the canonical DS‐1‐like backbone I2‐R2‐C2‐M2‐A2‐N2‐T2‐E2‐H2, whereas one strain (L116) carried a Wa‐like VP3 genotype (M1) within an otherwise DS‐1‐like genome. Whole‐genome phylogenies segregated the DS‐1‐like strains into two lineages—KN4‐like (with KN4, KN7, and L68) and L39‐like (with L39, L116, L222, and L286)—that each represented different globally circulating DS‐1‐like G3P[8] clades, consistent with at least two distinct introductions into Sabah. L116 VP3 shared < 80% with the other study strains, whereas for the remaining segments this was > 93%. Instead, L116 VP3 clustered with Wa‐like G12, suggesting a DS‐1‐like/Wa‐like intergenogroup (within backbone) reassortment event. Our findings contribute to understanding the evolutionary dynamics of globally emerging DS‐1‐like G3P[8] strains.

  • Open Access

    Identification of Murine Rotavirus Virulence Determinants Using Bidirectional Selective Passaging and a Reverse Genetics System

    by Saori Fukuda, Masanori Kugita, Yuki Akari, Johannes M. Dijkstra, Yoshiki Kawamura, Shizuko Nagao, Tetsushi Yoshikawa, Takayuki Murata, Satoshi Komoto

    Live-attenuated rotavirus (RV) vaccines are the most effective interventions for preventing RV gastroenteritis (RVGE) in young children. However, the molecular basis of attenuation remains not well understood. Here, we describe a compact but comprehensive strategy to identify RV virulence determinants by combining low-passage bidirectional selection, sequence analysis, and segment-level phenotype testing via a reverse genetics infectious system. Using the virulent murine RV strain EW, virulence was quantified by diarrhea severity/duration and body-weight gain. Serial passaging in cell culture selected an attenuated population, which regained virulence after passaging in suckling mice. Sequence comparison of the virulent and attenuated EW populations revealed only seven amino acid differences. We summarized literature describing attenuation/virulence-associated mutations in various RV group A (RVA) strains and found previous findings identical or similar to four of the seven mutations: NSP4-T45M, VP4-S470L, VP4-T612A, and VP7-T75P. Virulent- and attenuated-type EW variants of VP2, VP4, VP7, and NSP4 were introduced individually, or as NSP4/VP7 or VP4/VP7 pairs, into a simian SA11-L2 backbone using an 11-plasmid reverse genetics system. Phenotyping of rescued viruses consistently linked cell-culture–adapted VP4 to enhanced replication in vitro and reduced virulence in suckling mice. In vivo passaging strongly favored VP4 residue S470 over cell-culture-selected L470. More generally, our findings (i) underscore VP4 and VP7 as key determinants of EW virulence, (ii) provide a practical framework for identifying driver mutations underlying RVA attenuation, and (iii) highlight attenuation-associated substitutions shared across diverse RVAs.

  • Association of Rotavirus Infection With Biliary Atresia: A Retrospective Comparative Analysis of Virus‐Specific Antibodies

    by Yoshiki Kawamura, Masaru Ihira, Yuki Higashimoto, Toshihiro Yasui, Koichi Ito, Mitsuyoshi Suzuki, Nobuhiko Nagano, Katsumi Yoshizawa, Hiroki Miura, Jun‐Ichi Kawada, et al.

    Background: Biliary atresia (BA) is a severe infantile hepatobiliary disorder of unknown etiology. Perinatal rotavirus (RV) infection has been implicated in animal models of BA; however, supporting human data remains limited. The study investigated the serological evidence of recent RV infection in infants with BA using RV‐specific immunoglobulin (Ig)‐A, a marker of primary infection unaffected by maternal antibodies. Methods: Serum samples from 17 infants with BA and 30 age‐matched controls without gastrointestinal symptoms or prior RV vaccination were retrospectively analyzed. Anti‐RV‐IgA titers were measured by enzyme‐linked immunosorbent assay using purified WA‐strain virions. Cytomegalovirus (CMV)‐IgM and Epstein‐Barr virus (EBV)‐viral capsid antigen (VCA)‐IgM levels were assessed using commercial enzyme immunoassays. Results: RV‐IgA was detected in 70.6% (12/17) of the patients with BA versus 3.4% (1/29) of the controls ( p < 0.001). RV‐IgA titers were significantly higher in the BA group (median: interquartile range 2 8.0 :2 6.0 –2 10.0 ) than in the control group (2 3.5 :2 2.0 –2 4.8 ) ( p = 0.004). Among patients diagnosed with BA after 14 days of age, 84.6% (11/13) were RV‐IgA‐positive. CMV‐IgM was detected in three patients in the BA group and one individual in the control group, while EBV‐VCA‐IgM was negative in BA patients and positive in two controls; neither difference was statistically significant. Conclusions: The study findings support the potential association between RV infection and BA pathogenesis. However, the lack of an epidemiological reduction in BA following the introduction of the RV vaccine warrants caution in other studies. Further prospective multicenter studies are required to elucidate the causal role of RV infection in BA development.


  • Open Access

    A novel bat-like human G3P[10] rotavirus strain from Thailand shares its VP7 lineage with equine Erv105 and human DS-1-like G3P[8] strains: a possible origin in bats

    by Ratana Tacharoenmuang, Ratigorn Guntapong, Sompong Upachai, Phakapun Singchai, Teewasit Phatsaman, Karun Sutthiwarakom, Santip Kongjorn, Napa Onvimala, Tipsuda Luechakham, Busarawan Sriwanthana, et al.


  • Open Access

    A human sensory neuron model for varicella-zoster virus latency and reactivation in vitro .

    by Alexander Havelaar, Joseph Flot, Saori Fukuda, Anja W. M. de Jong, Roman Ivan Koning, Amber Schotting, Sem van 'T Geloof, Tomohiko Sadaoka, Georges M.G.M. Verjans, Paul R. Kinchington, et al.

    Varicella-zoster virus (VZV) is a ubiquitous human neurotropic alphaherpesvirus that establishes lifelong latency in sensory ganglionic neurons. Subsequent viral reactivation causes herpes zoster, a morbid disease often complicated by neuropathic pain. Mechanisms underlying VZV latency and reactivation are not understood, mostly due to the lack of permissive animal models and challenges of current in vitro latency modelling. Here, we evaluated HD10.6 cells, a simplified and easily expandable human sensory neuron line to model VZV latency and reactivation. Mature HD10.6 (mHD10.6) differentiated neurons supported productive VZV infection, viral DNA replication, production of infectious progeny, and viral spread in cultures. VZV infection was associated with limited cytopathic effects and ultrastructural changes. Infecting mHD10.6 neurons with cell-free VZV in the presence of antivirals resulted in a quiescent-persistent state, characterized by persistent VZV genomes with restricted VZV gene expression and absence of infectious virus. Importantly, VZV could be reactivated by treatment with capsaicin, as evidenced by increased lytic viral transcription and virus spread. In conclusion, this study establishes human HD10.6 neurons as a novel and scalable in vitro model for studying VZV latency and reactivation to identify virus and host factors governing latency that may serve as therapeutic targets to restrict VZV reactivation.

  • Open Access

    Generation of Recombinant Authentic Live Attenuated Human Rotavirus Vaccine Strain RIX4414 (Rotarix®) from Cloned cDNAs Using Reverse Genetics

    by Saori Fukuda, Masanori Kugita, Kanako Kumamoto, Yuki Akari, Yuki Higashimoto, Shizuko Nagao, Takayuki Murata, Tetsushi Yoshikawa, Koki Taniguchi, Satoshi Komoto

    The live attenuated human rotavirus vaccine strain RIX4414 (Rotarix®) is used worldwide to prevent severe rotavirus-induced diarrhea in infants. This strain was attenuated through the cell culture passaging of its predecessor, human strain 89-12, which resulted in multiple genomic mutations. However, the specific molecular reasons underlying its attenuation have remained elusive, primarily due to the absence of a suitable reverse genetics system enabling precise genetic manipulations. Therefore, we first completed the sequencing of its genome and then developed a reverse genetics system for the authentic RIX4414 virus. Our experimental results demonstrate that the rescued recombinant RIX4414 virus exhibits biological characteristics similar to those of the parental RIX4414 virus, both in vitro and in vivo. This novel reverse genetics system provides a powerful tool for investigating the molecular basis of RIX4414 attenuation and may facilitate the rational design of safer and more effective human rotavirus vaccines.


  • Development of recombinant rotavirus carrying herpes simplex virus 2 glycoprotein D gene based on reverse genetics technology

    by Yoshiki Kawamura, Satoshi Komoto, Saori Fukuda, Masanori Kugita, Shuang Tang, Amita Patel, Julianna R. Pieknik, Shizuko Nagao, Koki Taniguchi, Philip R. Krause, et al.

    Vaccine development for herpes simplex virus 2 (HSV‐2) has been attempted, but no vaccines are yet available. A plasmid‐based reverse genetics system for Rotavirus (RV), which can cause gastroenteritis, allows the generation of recombinant RV containing foreign genes. In this study, we sought to develop simian RV (SA11) as a vector to express HSV‐2 glycoprotein D (gD2) and evaluated its immunogenicity in mice. We generated the recombinant SA11‐gD2 virus (rSA11‐gD2) and confirmed its ability to express gD2 in vitro. The virus was orally inoculated into suckling BALB/c mice and into 8‐week‐old mice. Serum IgG and IgA titers against RV and gD2 were measured by ELISA. In the 8‐week‐old mice inoculated with rSA11‐gD2, significant increases in not only antibodies against RV but also IgG against gD2 were demonstrated. In the suckling mice, antibodies against RV were induced, but gD2 antibody was not detected. Diarrhea observed after the first inoculation of rSA11‐gD2 in suckling mice was similar to that induced by the parent virus. A gD2 expressing simian RV recombinant, which was orally inoculated, induced IgG against gD2. This strategy holds possibility for genital herpes vaccine development.


  • Open Access

    Full genome-based characterization of an Asian G3P[6] human rotavirus strain found in a diarrheic child in Japan: Evidence for porcine-to-human zoonotic transmission

    by Yuki Akari, Riona Hatazawa, Haruo Kuroki, Hiroaki Ito, Manami Negoro, Takaaki Tanaka, Haruna Miwa, Katsumi Sugiura, Masakazu Umemoto, Shigeki Tanaka, et al.